{"cluster": 20, "subcluster": 24, "abstract_summ": "Although commercial testing systems are becoming available, there will likely be insufficient numbers of such tests due to high demand.This review focused on testing in the United States as this testing is evolving whereas in China and other countries such as South Korea testing is widely available and includes both molecular testing for SARS\u2010CoV\u20102 as well as serological testing using both ELISA methodology and lateral flow immunoassay methodology.We initiated smart test ordering, interfaced all testing platforms with our electronic medical record, and went from zero testing capacity, to testing hundreds of healthcare workers and patients daily, within three weeks.In addition, multiple other tests were put in place under a separate authorization by a Presidential memorandum in early March allowing laboratories that carry Clinical Laboratory Improvement Amendment (CLIA) certification to put tests in place without an EUA from the FDA.This process was extremely complex, due to the limited availability of needed reagents, but outreach to our research scientists and to multiple diagnostic laboratory companies and government officials enabled us to implement both FDA authorized and laboratory developed testing (LDT)-based testing protocols.", "title_summ": "Rapid Resolution of a Critical COVID-19 Testing BottleneckClinical Testing For Covid-19Rapid Implementation of a SARS-CoV-2 Diagnostic qRT-PCR Test with Emergency Use Authorization at a Large Academic Safety-Net HospitalAn Evolving Approach to the Laboratory Assessment of COVID\u201019Diagnostic Performance of a Rapid Point of Care Test for SARS\u2010CoV\u20102 in an Urban EDA how-to-guide to building a robust SARS-CoV-2 testing program at a university-based health systemDesign and clinical validation of a 3D-printed nasopharyngeal swab for COVID-19 testingBlueprint for a Pop-up SARS-CoV-2 Testing LabA blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilitiesOpen Development and Clinical Validation Of Multiple 3D-Printed Sample-Collection Swabs:SettingRapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacityOpen Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs:Rapid Resolution of a Critical COVID-19 Testing Bottleneck.", "title_abstract_phrases": "Although commercial testing systems are becoming available, there will likely be insufficient numbers of such tests due to high demand.This review focused on testing in the United States as this testing is evolving whereas in China and other countries such as South Korea testing is widely available and includes both molecular testing for SARS\u2010CoV\u20102 as well as serological testing using both ELISA methodology and lateral flow immunoassay methodology.A how-to-guide to building a robust SARS-CoV-2 testing program at a university-based health systemWhen South Florida became a hotspot for COVID-19 disease in March 2020, we faced an urgent need to develop test capability to detect SARS-CoV-2 infection.We initiated smart test ordering, interfaced all testing platforms with our electronic medical record, and went from zero testing capacity, to testing hundreds of healthcare workers and patients daily, within three weeks.Our procedures for implementing the technical, regulatory, and data management workstreams necessary for clinical sample processing provide a roadmap to aid others in setting up similar testing centers."}